slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 6,031-6,060
Pages 350
Rows per page 30
Slide type
6,031-6,060 of 10,471
05
The slide uses a process flow diagram to show the funnel from potential partnerships to active clinical programs.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Traction1 hit
06
The chart shows a cumulative growth of partnerships over time from 2017 to 2023.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses donut charts to visualize the distribution of milestone events across IND, Pre-Pivotal, and Pivotal or Later phases.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
16
The diagram uses concentric circles to represent clinical phases and color-coded dots to represent cell approaches (allogeneic vs autologous).MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
17
The slide uses a Vitruvian Man-style graphic to represent the breadth of therapeutic applications.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
06
Nemaura Medical | Investor Presentation Deck | 19 slidesNemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations Beat · Traction1 hit
07
The slide presents two line charts: one comparing BGM vs Invasive CGM, and one showing raw sugarBEAT data.Nemaura Medical | Investor Presentation Deck | 19 slides · Nemaura Medical
Pitch deck Investor relations Beat · Traction1 hit
06
The slide uses a consistent three-column layout to compare key performance metrics across three distinct game titles.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
08
Includes growth percentage annotations between 2020 and 2022 for each metric.Nexters | Investor Presentation Deck | 18 slides · GDEV
Pitch deck Investor relations 1 hit
13
The slide uses dot plots to show IC50 values for different drugs across fusion partners and mutations, and a bar chart to show tumor regression efficacy.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
19
The chart displays dose-dependent exposure over 24 hours, with horizontal dashed lines representing efficacy targets for different ROS1 variants in CNS and periphery.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
20
Clinical trial data table showing efficacy metrics for NVL-520.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
21
Clinical trial data visualization (waterfall plot) with patient-level characteristics table below.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
22
Swimmer plot showing patient-level treatment duration, response status, and ongoing treatment status.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
23
Includes a spider plot (target lesion change) and a bar chart (allele clearance).Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
Includes patient case study with longitudinal MRI scans.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
27
Includes clinical trial data cut-offs and patient enrollment numbers.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
28
The slide details specific patient cohorts (2a-2e) with varying treatment histories and trial objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
32
The slide uses a split-panel layout to contrast in vitro IC50 data with in vivo tumor regression data.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
39
The chart displays patient-level data categorized by dose (15mg to 200mg) and mutation type, highlighting the efficacy of the drug in clearing specific ALK mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
40
The slide presents clinical trial data for NVL-655, showing efficacy across different resistance mutation profiles and prior treatment histories.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
41
Clinical trial data visualization showing ORR and best percentage change in target lesions.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
42
The chart is a swimmer plot, a standard visualization in oncology clinical trials to show time-to-event data for individual patients.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
43
Includes two patient case studies with MRI scans showing tumor reduction.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
05
Snap Inc | Investor Presentation Deck | 50 slidesSnap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
06
The chart displays consistent growth across all three regions over 19 quarters.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
10
The chart uses a cumulative area/line hybrid to visualize growth while annotating product launches chronologically.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a combination of a metric-focused yellow card and visual product screenshots to demonstrate traction.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses screenshots of the Snapchat interface to demonstrate content consumption.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Market Sizing1 hit
31
The slide uses flag icons to represent the countries where this penetration is achieved.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit